Anchiano Therapeutics Ltd. logo

Anchiano Therapeutics Ltd. ANCN

$ 4.71 5.37%

Country

israelIsrael

IPO year

2019

Industry

-

Stock Exchange

NASDAQ GLOBAL

CEO

Dr. Frank G. Haluska

Employees in the company

16

Shares

-

Market Cap[1]

$ 34.9 M

EBITDA (LTM)

$ -57.1 M

P/E (LTM)

-

P/S (LTM)

-

EPS (LTM)

-

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.